Search

everythinglearnresearchcommunity

for

Search:↓

TrichoSolTM is safe for hair loss treatments with specific ingredient stability for up to 180 days.

The compounded topical solution is safe, stable, and effective for personalized alopecia treatment.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

The new minoxidil hydrogel is a promising alternative for hair loss treatment, with similar effectiveness and less skin irritation.

Topical JAK inhibitors may help children with alopecia areata regrow hair.

The topical solution improved hair density and appearance in men with androgenetic alopecia.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.

The new minoxidil lotion using Aloplus Total is stable and can be mixed with other ingredients for treating hair loss.

Color changes in Minoxidil hair products do not affect their effectiveness.

Galenic lotions can effectively treat different patterns of hair thinning in men and women.

Different treatments for Hidradenitis suppurativa range from antibiotics and hormonal therapies to surgery, depending on severity.

Topical corticosteroids are the best initial treatment for children's alopecia areata.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Testosterone can help premenopausal and postmenopausal women with low sexual desire, but its long-term safety is unclear and it's not widely approved for this use.

Combination therapies for androgenetic alopecia work best but can have significant side effects and costs.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

The symposium concluded that a specific lipid might cause hair loss, inflammation is a key factor, and stem cells in bald scalps aren't working right, suggesting new treatment targets.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

Skin, hair, and nail changes can help detect eating disorders early.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Transfersomes are better than liposomes for targeting hair follicles in alopecia treatment.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

UK dermatologists commonly use corticosteroids and minoxidil to treat hair loss conditions.

GLP-1 receptor agonists help with weight loss but need to be combined with other treatments for best results.

Refugee patients face long wait times for dermatology care, worsening health disparities.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.